Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Disulfides | 12 | 2023 | 467 | 4.430 |
Why?
|
Protein Folding | 14 | 2023 | 872 | 3.100 |
Why?
|
Peptides | 10 | 2023 | 4353 | 1.810 |
Why?
|
Protein Precursors | 5 | 2023 | 1134 | 1.200 |
Why?
|
Kidney Transplantation | 11 | 2024 | 4300 | 1.100 |
Why?
|
Proteins | 8 | 2019 | 6006 | 1.000 |
Why?
|
Pro-Opiomelanocortin | 1 | 2023 | 138 | 0.870 |
Why?
|
Peptide Fragments | 4 | 2023 | 5151 | 0.860 |
Why?
|
Enterotoxigenic Escherichia coli | 1 | 2023 | 32 | 0.840 |
Why?
|
Enterotoxins | 2 | 2023 | 365 | 0.820 |
Why?
|
Bombyx | 1 | 2022 | 58 | 0.790 |
Why?
|
Living Donors | 9 | 2024 | 651 | 0.780 |
Why?
|
Glutathione | 3 | 2019 | 585 | 0.680 |
Why?
|
Hydrolases | 4 | 2009 | 146 | 0.630 |
Why?
|
Hot Temperature | 2 | 2023 | 1440 | 0.580 |
Why?
|
Bacterial Toxins | 1 | 2023 | 923 | 0.560 |
Why?
|
Uric Acid | 8 | 2021 | 806 | 0.560 |
Why?
|
Hyperuricemia | 4 | 2021 | 223 | 0.540 |
Why?
|
Antigen-Antibody Complex | 2 | 2010 | 513 | 0.520 |
Why?
|
Gout | 5 | 2022 | 621 | 0.520 |
Why?
|
Protein Processing, Post-Translational | 3 | 2020 | 1967 | 0.520 |
Why?
|
Still's Disease, Adult-Onset | 2 | 2006 | 23 | 0.520 |
Why?
|
Escherichia coli Proteins | 1 | 2023 | 1057 | 0.510 |
Why?
|
Sulfhydryl Compounds | 2 | 2019 | 296 | 0.510 |
Why?
|
Models, Molecular | 5 | 2024 | 5404 | 0.500 |
Why?
|
Protein Disulfide-Isomerases | 2 | 2014 | 210 | 0.500 |
Why?
|
Cytomegalovirus Infections | 1 | 2022 | 839 | 0.500 |
Why?
|
Sodium Channels | 1 | 2017 | 341 | 0.500 |
Why?
|
Polyarteritis Nodosa | 2 | 2005 | 70 | 0.480 |
Why?
|
Protein Unfolding | 1 | 2014 | 57 | 0.450 |
Why?
|
Guanylate Cyclase | 3 | 2023 | 206 | 0.440 |
Why?
|
Acute Lung Injury | 1 | 2017 | 378 | 0.430 |
Why?
|
Oligopeptides | 3 | 2023 | 1194 | 0.410 |
Why?
|
Muramidase | 1 | 2012 | 164 | 0.400 |
Why?
|
Rheumatoid Factor | 2 | 2010 | 184 | 0.390 |
Why?
|
Models, Chemical | 1 | 2014 | 611 | 0.390 |
Why?
|
Retroperitoneal Fibrosis | 1 | 2012 | 42 | 0.390 |
Why?
|
Intramolecular Oxidoreductases | 2 | 2022 | 105 | 0.380 |
Why?
|
Kidney | 9 | 2024 | 7064 | 0.380 |
Why?
|
Churg-Strauss Syndrome | 1 | 2012 | 75 | 0.370 |
Why?
|
Spiders | 1 | 2011 | 11 | 0.370 |
Why?
|
Chromatography, High Pressure Liquid | 5 | 2023 | 1539 | 0.370 |
Why?
|
Escherichia coli | 3 | 2022 | 4211 | 0.370 |
Why?
|
Amino Acid Sequence | 11 | 2024 | 13423 | 0.370 |
Why?
|
Lipocalins | 2 | 2022 | 161 | 0.360 |
Why?
|
Silk | 1 | 2011 | 93 | 0.350 |
Why?
|
Substrate Specificity | 5 | 2024 | 1753 | 0.340 |
Why?
|
Citrulline | 2 | 2009 | 107 | 0.330 |
Why?
|
Plasmapheresis | 2 | 2006 | 207 | 0.310 |
Why?
|
Kinetics | 5 | 2023 | 6333 | 0.310 |
Why?
|
Oxidation-Reduction | 4 | 2023 | 2225 | 0.280 |
Why?
|
Graft Survival | 5 | 2024 | 3900 | 0.260 |
Why?
|
Lupus Vasculitis, Central Nervous System | 1 | 2006 | 32 | 0.260 |
Why?
|
Lupus Erythematosus, Systemic | 3 | 2023 | 2170 | 0.260 |
Why?
|
Guanidine | 1 | 2005 | 35 | 0.250 |
Why?
|
Kidney Diseases | 3 | 2022 | 2103 | 0.250 |
Why?
|
Skin Diseases, Vascular | 1 | 2005 | 41 | 0.250 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2010 | 3813 | 0.250 |
Why?
|
Prostaglandin H2 | 2 | 2022 | 10 | 0.250 |
Why?
|
Xanthine | 1 | 2004 | 11 | 0.240 |
Why?
|
Mesenteric Artery, Superior | 1 | 2005 | 96 | 0.240 |
Why?
|
Uricosuric Agents | 2 | 2021 | 30 | 0.240 |
Why?
|
Receptors, Peptide | 2 | 2005 | 280 | 0.240 |
Why?
|
Xanthine Oxidase | 1 | 2004 | 69 | 0.240 |
Why?
|
Nephrectomy | 2 | 2019 | 949 | 0.230 |
Why?
|
Galactosylceramides | 1 | 2024 | 90 | 0.220 |
Why?
|
Histones | 3 | 2009 | 2592 | 0.220 |
Why?
|
Benzothiazoles | 2 | 2021 | 248 | 0.220 |
Why?
|
Glycosides | 1 | 2024 | 100 | 0.220 |
Why?
|
Lenses | 1 | 2023 | 42 | 0.220 |
Why?
|
Purine-Pyrimidine Metabolism, Inborn Errors | 1 | 2003 | 8 | 0.220 |
Why?
|
Protein Conformation | 5 | 2021 | 3955 | 0.210 |
Why?
|
Glomerular Filtration Rate | 6 | 2024 | 2226 | 0.210 |
Why?
|
Hypoxanthine Phosphoribosyltransferase | 1 | 2003 | 69 | 0.210 |
Why?
|
Purine Nucleotides | 1 | 2003 | 27 | 0.210 |
Why?
|
Selenocysteine | 2 | 2014 | 127 | 0.210 |
Why?
|
Binding Sites | 6 | 2024 | 6017 | 0.210 |
Why?
|
Arginine | 2 | 2005 | 923 | 0.200 |
Why?
|
Arthritis, Rheumatoid | 2 | 2010 | 3777 | 0.200 |
Why?
|
Caco-2 Cells | 1 | 2023 | 365 | 0.200 |
Why?
|
Gout Suppressants | 3 | 2021 | 177 | 0.200 |
Why?
|
Trypsin | 1 | 2022 | 491 | 0.190 |
Why?
|
5'-Nucleotidase | 1 | 2003 | 164 | 0.190 |
Why?
|
Arthralgia | 1 | 2005 | 459 | 0.190 |
Why?
|
Lens, Crystalline | 1 | 2023 | 387 | 0.190 |
Why?
|
Prostaglandin D2 | 1 | 2021 | 108 | 0.190 |
Why?
|
Mammals | 2 | 2023 | 1136 | 0.180 |
Why?
|
Ultrasonography, Doppler | 1 | 2023 | 463 | 0.180 |
Why?
|
Adenosine Deaminase | 1 | 2003 | 252 | 0.180 |
Why?
|
Anti-Infective Agents, Urinary | 1 | 2020 | 28 | 0.180 |
Why?
|
Vascular Resistance | 1 | 2023 | 940 | 0.170 |
Why?
|
Ureter | 1 | 2022 | 370 | 0.170 |
Why?
|
Urea | 2 | 2019 | 446 | 0.170 |
Why?
|
Angiography | 1 | 2005 | 1598 | 0.170 |
Why?
|
Japan | 5 | 2022 | 1418 | 0.170 |
Why?
|
Mycophenolic Acid | 1 | 2022 | 350 | 0.170 |
Why?
|
Contactins | 1 | 2019 | 21 | 0.170 |
Why?
|
Serine Endopeptidases | 1 | 2024 | 1026 | 0.160 |
Why?
|
Peptide Hydrolases | 1 | 2022 | 610 | 0.160 |
Why?
|
Cataract Extraction | 1 | 2023 | 465 | 0.160 |
Why?
|
Reperfusion | 1 | 2020 | 266 | 0.160 |
Why?
|
Catalytic Domain | 1 | 2021 | 698 | 0.160 |
Why?
|
Donor Selection | 1 | 2021 | 240 | 0.160 |
Why?
|
Protein Stability | 1 | 2020 | 580 | 0.160 |
Why?
|
Thymoma | 1 | 2020 | 191 | 0.150 |
Why?
|
Tacrolimus | 1 | 2022 | 750 | 0.150 |
Why?
|
Kidney Function Tests | 1 | 2020 | 681 | 0.150 |
Why?
|
Fever | 1 | 2005 | 1620 | 0.150 |
Why?
|
Point Mutation | 1 | 2022 | 1594 | 0.140 |
Why?
|
Graft Rejection | 4 | 2024 | 4505 | 0.140 |
Why?
|
Thymus Neoplasms | 1 | 2020 | 277 | 0.140 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 3 | 2009 | 505 | 0.140 |
Why?
|
Polysaccharides | 1 | 2024 | 1024 | 0.140 |
Why?
|
Cell Adhesion | 1 | 2023 | 3102 | 0.140 |
Why?
|
Zinc Fingers | 1 | 2019 | 577 | 0.140 |
Why?
|
Hydrogen-Ion Concentration | 2 | 2012 | 2488 | 0.140 |
Why?
|
Humans | 47 | 2024 | 768393 | 0.140 |
Why?
|
Recombinant Proteins | 3 | 2022 | 6510 | 0.140 |
Why?
|
Swine | 2 | 2023 | 5994 | 0.140 |
Why?
|
Intraoperative Care | 1 | 2020 | 771 | 0.130 |
Why?
|
Urinary Tract Infections | 1 | 2022 | 806 | 0.130 |
Why?
|
Colchicine | 1 | 2017 | 257 | 0.130 |
Why?
|
DNA Mutational Analysis | 1 | 2024 | 4120 | 0.130 |
Why?
|
Antibodies, Monoclonal | 2 | 2010 | 9261 | 0.120 |
Why?
|
Neoplasms | 2 | 2023 | 22385 | 0.120 |
Why?
|
Animals | 13 | 2023 | 169337 | 0.120 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 2017 | 761 | 0.120 |
Why?
|
Antibodies | 1 | 2023 | 2425 | 0.120 |
Why?
|
Prednisolone | 2 | 2006 | 327 | 0.120 |
Why?
|
Creatinine | 1 | 2020 | 1915 | 0.120 |
Why?
|
Estrogens, Non-Steroidal | 1 | 2014 | 52 | 0.120 |
Why?
|
Pulmonary Edema | 1 | 2017 | 409 | 0.120 |
Why?
|
Pulmonary Alveoli | 1 | 2017 | 665 | 0.110 |
Why?
|
Reference Values | 3 | 2020 | 4941 | 0.110 |
Why?
|
Pharmaceutical Preparations | 1 | 2021 | 1088 | 0.110 |
Why?
|
Immunosuppressive Agents | 2 | 2022 | 4209 | 0.110 |
Why?
|
Chromatography, Reverse-Phase | 1 | 2012 | 24 | 0.100 |
Why?
|
Adaptation, Physiological | 1 | 2019 | 1315 | 0.100 |
Why?
|
Oxidoreductases | 1 | 2014 | 412 | 0.100 |
Why?
|
Static Electricity | 1 | 2012 | 261 | 0.100 |
Why?
|
Imaging, Three-Dimensional | 1 | 2005 | 4076 | 0.100 |
Why?
|
Solutions | 1 | 2012 | 409 | 0.100 |
Why?
|
Mutation | 5 | 2024 | 30228 | 0.090 |
Why?
|
Dexamethasone | 1 | 2019 | 1965 | 0.090 |
Why?
|
Protein Structure, Secondary | 2 | 2012 | 1216 | 0.090 |
Why?
|
Neoplasm Proteins | 2 | 2020 | 3610 | 0.090 |
Why?
|
Circular Dichroism | 1 | 2011 | 337 | 0.090 |
Why?
|
Phenols | 1 | 2014 | 520 | 0.090 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2019 | 1536 | 0.090 |
Why?
|
Collagen Diseases | 1 | 2010 | 39 | 0.090 |
Why?
|
Prions | 1 | 2012 | 177 | 0.090 |
Why?
|
Electroencephalography | 1 | 2006 | 6317 | 0.090 |
Why?
|
Ultrasonography | 1 | 2023 | 6001 | 0.080 |
Why?
|
Antibodies, Antineutrophil Cytoplasmic | 1 | 2012 | 294 | 0.080 |
Why?
|
Immunologic Factors | 1 | 2019 | 1597 | 0.080 |
Why?
|
Lipopolysaccharides | 1 | 2017 | 2215 | 0.080 |
Why?
|
Recovery of Function | 1 | 2019 | 2990 | 0.080 |
Why?
|
Tomography, X-Ray Computed | 3 | 2012 | 20765 | 0.080 |
Why?
|
Genetic Predisposition to Disease | 2 | 2022 | 18048 | 0.080 |
Why?
|
Molecular Sequence Data | 7 | 2012 | 17626 | 0.080 |
Why?
|
beta Karyopherins | 1 | 2007 | 46 | 0.070 |
Why?
|
Protein Structure, Tertiary | 3 | 2014 | 3779 | 0.070 |
Why?
|
Benzhydryl Compounds | 1 | 2014 | 940 | 0.070 |
Why?
|
Kidney Failure, Chronic | 1 | 2019 | 2491 | 0.070 |
Why?
|
Prednisone | 1 | 2012 | 1567 | 0.070 |
Why?
|
Remission Induction | 2 | 2019 | 2407 | 0.070 |
Why?
|
Receptors, Guanylate Cyclase-Coupled | 2 | 2005 | 15 | 0.070 |
Why?
|
Amyloid | 1 | 2012 | 854 | 0.070 |
Why?
|
Acetylation | 1 | 2009 | 1053 | 0.070 |
Why?
|
Male | 19 | 2023 | 364902 | 0.070 |
Why?
|
Treatment Outcome | 8 | 2024 | 65379 | 0.060 |
Why?
|
Pulse Therapy, Drug | 1 | 2005 | 37 | 0.060 |
Why?
|
Karyopherins | 1 | 2006 | 134 | 0.060 |
Why?
|
Nervous System | 1 | 2009 | 547 | 0.060 |
Why?
|
Specimen Handling | 1 | 2010 | 708 | 0.060 |
Why?
|
Filtration | 1 | 2006 | 228 | 0.060 |
Why?
|
Severity of Illness Index | 2 | 2020 | 15939 | 0.060 |
Why?
|
Tubulin | 1 | 2009 | 695 | 0.060 |
Why?
|
Plasma Exchange | 1 | 2006 | 160 | 0.060 |
Why?
|
Gastrointestinal Hormones | 1 | 2005 | 101 | 0.060 |
Why?
|
Immunologic Tests | 1 | 2005 | 104 | 0.060 |
Why?
|
Azathioprine | 1 | 2006 | 354 | 0.060 |
Why?
|
Pericarditis | 1 | 2006 | 136 | 0.060 |
Why?
|
Gene Expression | 1 | 2017 | 7598 | 0.060 |
Why?
|
Blood Pressure | 1 | 2020 | 8541 | 0.060 |
Why?
|
Retrospective Studies | 9 | 2024 | 81801 | 0.060 |
Why?
|
Methylprednisolone | 1 | 2005 | 387 | 0.060 |
Why?
|
Amylases | 1 | 2024 | 171 | 0.060 |
Why?
|
Adult | 13 | 2024 | 223640 | 0.050 |
Why?
|
Catalysis | 1 | 2005 | 768 | 0.050 |
Why?
|
Genome-Wide Association Study | 2 | 2020 | 12778 | 0.050 |
Why?
|
Membrane Glycoproteins | 1 | 2014 | 3712 | 0.050 |
Why?
|
Lesch-Nyhan Syndrome | 1 | 2003 | 16 | 0.050 |
Why?
|
MicroRNAs | 1 | 2019 | 3804 | 0.050 |
Why?
|
Cerebrospinal Fluid | 1 | 2006 | 545 | 0.050 |
Why?
|
Drinking | 1 | 2024 | 197 | 0.050 |
Why?
|
Biopsy | 2 | 2024 | 6808 | 0.050 |
Why?
|
Myositis | 1 | 2006 | 276 | 0.050 |
Why?
|
Methylation | 1 | 2005 | 1076 | 0.050 |
Why?
|
Disorders of Excessive Somnolence | 1 | 2006 | 277 | 0.050 |
Why?
|
Aminoisobutyric Acids | 1 | 2022 | 39 | 0.050 |
Why?
|
Lupus Nephritis | 1 | 2006 | 322 | 0.050 |
Why?
|
Middle Aged | 12 | 2021 | 223491 | 0.050 |
Why?
|
Restriction Mapping | 1 | 2002 | 849 | 0.050 |
Why?
|
Communicable Diseases | 1 | 2010 | 873 | 0.050 |
Why?
|
Hypertension | 1 | 2021 | 8615 | 0.050 |
Why?
|
Binding, Competitive | 1 | 2002 | 1142 | 0.050 |
Why?
|
Cloning, Molecular | 2 | 2006 | 4168 | 0.050 |
Why?
|
Biocatalysis | 1 | 2021 | 168 | 0.050 |
Why?
|
Multiple Myeloma | 1 | 2019 | 5192 | 0.050 |
Why?
|
Glycosylation | 1 | 2024 | 1100 | 0.040 |
Why?
|
Central Venous Pressure | 1 | 2020 | 80 | 0.040 |
Why?
|
Cyclopropanes | 1 | 2022 | 437 | 0.040 |
Why?
|
Leucine | 1 | 2022 | 548 | 0.040 |
Why?
|
Genetic Loci | 2 | 2020 | 2630 | 0.040 |
Why?
|
Proline | 1 | 2022 | 455 | 0.040 |
Why?
|
Lactams, Macrocyclic | 1 | 2022 | 319 | 0.040 |
Why?
|
Cyclophosphamide | 1 | 2006 | 2226 | 0.040 |
Why?
|
Pyrrolidines | 1 | 2022 | 340 | 0.040 |
Why?
|
Quinoxalines | 1 | 2022 | 297 | 0.040 |
Why?
|
Glucose Transport Proteins, Facilitative | 1 | 2019 | 57 | 0.040 |
Why?
|
Eye | 1 | 2023 | 712 | 0.040 |
Why?
|
Nuclear Magnetic Resonance, Biomolecular | 1 | 2022 | 508 | 0.040 |
Why?
|
Ligands | 2 | 2005 | 3283 | 0.040 |
Why?
|
Thymectomy | 1 | 2020 | 200 | 0.040 |
Why?
|
Isoantibodies | 1 | 2023 | 682 | 0.040 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2021 | 640 | 0.040 |
Why?
|
Memory Disorders | 1 | 2006 | 1203 | 0.040 |
Why?
|
Pneumonia, Pneumocystis | 1 | 2020 | 242 | 0.040 |
Why?
|
Preoperative Period | 1 | 2021 | 564 | 0.040 |
Why?
|
Crystallography, X-Ray | 3 | 2008 | 1952 | 0.040 |
Why?
|
Lung | 1 | 2017 | 10089 | 0.040 |
Why?
|
Autoimmune Diseases | 1 | 2010 | 2257 | 0.040 |
Why?
|
Muscles | 1 | 2003 | 1582 | 0.040 |
Why?
|
Aged | 7 | 2022 | 171562 | 0.040 |
Why?
|
Adenosine | 1 | 2003 | 817 | 0.040 |
Why?
|
Hypertrophy | 1 | 2019 | 562 | 0.040 |
Why?
|
HLA Antigens | 1 | 2023 | 1337 | 0.040 |
Why?
|
Mice | 3 | 2022 | 82017 | 0.040 |
Why?
|
Intraocular Pressure | 1 | 2023 | 1304 | 0.040 |
Why?
|
Administration, Oral | 1 | 2005 | 4039 | 0.040 |
Why?
|
Thoracic Surgery, Video-Assisted | 1 | 2020 | 296 | 0.030 |
Why?
|
Adrenal Cortex Hormones | 1 | 2006 | 1890 | 0.030 |
Why?
|
Molecular Structure | 1 | 2021 | 1884 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2020 | 10776 | 0.030 |
Why?
|
Benzimidazoles | 1 | 2022 | 864 | 0.030 |
Why?
|
Genotype | 2 | 2022 | 13042 | 0.030 |
Why?
|
Crystallization | 2 | 2008 | 521 | 0.030 |
Why?
|
Asymptomatic Diseases | 1 | 2019 | 589 | 0.030 |
Why?
|
Female | 11 | 2022 | 397089 | 0.030 |
Why?
|
Glucocorticoids | 1 | 2005 | 2168 | 0.030 |
Why?
|
Area Under Curve | 1 | 2020 | 1642 | 0.030 |
Why?
|
Protein Binding | 2 | 2021 | 9343 | 0.030 |
Why?
|
Anti-Inflammatory Agents | 1 | 2005 | 1813 | 0.030 |
Why?
|
Drug Combinations | 1 | 2022 | 2079 | 0.030 |
Why?
|
Necrosis | 1 | 2020 | 1621 | 0.030 |
Why?
|
Postoperative Period | 1 | 2020 | 1830 | 0.030 |
Why?
|
Lymphocytes | 1 | 2003 | 2611 | 0.030 |
Why?
|
Hepacivirus | 1 | 2022 | 1342 | 0.030 |
Why?
|
Peroxiredoxins | 1 | 2014 | 51 | 0.030 |
Why?
|
Recurrence | 1 | 2006 | 8506 | 0.030 |
Why?
|
Erythrocytes | 1 | 2003 | 2421 | 0.030 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 1517 | 0.030 |
Why?
|
Tissue Donors | 1 | 2023 | 2389 | 0.030 |
Why?
|
Body Weight | 1 | 2023 | 4629 | 0.020 |
Why?
|
Sequence Alignment | 2 | 2007 | 2176 | 0.020 |
Why?
|
Sulfonamides | 1 | 2022 | 1980 | 0.020 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2021 | 3781 | 0.020 |
Why?
|
Sequence Homology, Amino Acid | 2 | 2005 | 2750 | 0.020 |
Why?
|
Renal Dialysis | 1 | 2020 | 1802 | 0.020 |
Why?
|
Incidence | 2 | 2020 | 21544 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2005 | 13020 | 0.020 |
Why?
|
Forecasting | 1 | 2019 | 2948 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2022 | 3064 | 0.020 |
Why?
|
HeLa Cells | 1 | 2014 | 3088 | 0.020 |
Why?
|
Heterogeneous-Nuclear Ribonucleoprotein D | 1 | 2007 | 9 | 0.020 |
Why?
|
Nuclear Localization Signals | 1 | 2007 | 78 | 0.020 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2017 | 2276 | 0.020 |
Why?
|
X-Ray Diffraction | 1 | 2008 | 417 | 0.020 |
Why?
|
Postoperative Complications | 2 | 2020 | 15881 | 0.020 |
Why?
|
Inclusion Bodies | 1 | 2008 | 279 | 0.020 |
Why?
|
Synchrotrons | 1 | 2006 | 40 | 0.020 |
Why?
|
Solubility | 1 | 2008 | 1085 | 0.020 |
Why?
|
Crystallography | 1 | 2006 | 111 | 0.020 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2007 | 432 | 0.020 |
Why?
|
Cyanogen Bromide | 1 | 2005 | 75 | 0.020 |
Why?
|
Survival Rate | 1 | 2020 | 12870 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2002 | 7880 | 0.020 |
Why?
|
Imines | 1 | 2005 | 26 | 0.020 |
Why?
|
Calcimycin | 1 | 2005 | 214 | 0.020 |
Why?
|
Isomerism | 1 | 2005 | 198 | 0.020 |
Why?
|
Ionophores | 1 | 2005 | 108 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2021 | 8051 | 0.020 |
Why?
|
Peptide Mapping | 1 | 2005 | 260 | 0.020 |
Why?
|
Ribonucleoproteins | 1 | 2007 | 359 | 0.020 |
Why?
|
DNA, Complementary | 1 | 2008 | 1992 | 0.010 |
Why?
|
Models, Statistical | 1 | 2019 | 5099 | 0.010 |
Why?
|
Chronic Disease | 1 | 2019 | 9379 | 0.010 |
Why?
|
HL-60 Cells | 1 | 2005 | 364 | 0.010 |
Why?
|
Indicators and Reagents | 1 | 2005 | 455 | 0.010 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 2007 | 567 | 0.010 |
Why?
|
Natriuretic Peptides | 1 | 2005 | 156 | 0.010 |
Why?
|
Age Factors | 1 | 2019 | 18471 | 0.010 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2006 | 1682 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2022 | 16028 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2020 | 22296 | 0.010 |
Why?
|
Phenotype | 1 | 2020 | 16721 | 0.010 |
Why?
|
Neurodegenerative Diseases | 1 | 2009 | 1094 | 0.010 |
Why?
|
Prognosis | 1 | 2020 | 30022 | 0.010 |
Why?
|
Time Factors | 1 | 2021 | 40272 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 1 | 2007 | 3731 | 0.010 |
Why?
|
Risk Assessment | 1 | 2020 | 24318 | 0.010 |
Why?
|
Rats | 1 | 2014 | 23835 | 0.010 |
Why?
|
Prevalence | 1 | 2015 | 15872 | 0.010 |
Why?
|
RNA-Binding Proteins | 1 | 2006 | 1883 | 0.010 |
Why?
|
Cohort Studies | 1 | 2020 | 41795 | 0.010 |
Why?
|
Prospective Studies | 1 | 2017 | 54920 | 0.010 |
Why?
|
Young Adult | 1 | 2019 | 60049 | 0.010 |
Why?
|
Risk Factors | 1 | 2019 | 74962 | 0.010 |
Why?
|
United States | 1 | 2020 | 73150 | 0.010 |
Why?
|
Neurons | 1 | 2009 | 9513 | 0.010 |
Why?
|